Award
Delivery Order #SPE2D326F6964
Delivery Order for Ketorolac Vials by Fresenius Kabi under IDV Contract
Buyer
Defense Logistics Agency
Award Amount
$213.14
Ceiling
$213.14
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2D326F6964
NAICS
325411
This award represents a delivery order under an existing indefinite delivery contract previously awarded to Fresenius Kabi, LLC, a leading pharmaceutical company specializing in critical medical supplies for the U.S. Department of Defense. The order procures Ketorolac 30 mg/ml vials, an essential medication used for pain management in military medical settings. This delivery is part of a multi-year agreement enhancing medical preparedness and operational readiness of U.S. Armed Forces by ensuring timely availability of pharmaceutical products. The scope of work covers the manufacture and delivery of the specified medication dose within a short performance window, reflecting urgent and specific operational requirements. The original indefinite delivery contract was competitively procured, emphasizing transparent and responsible acquisition practices. This delivery order continues to support the ongoing supply chain stability for critical pharmaceuticals, vital for effective military healthcare. The brief timeline of this order indicates a scheduled, targeted fulfillment under the broader contract vehicle.
Description
4571026596!KETOROLAC 30 MG/ML VIALML